Overview

Dexamethasone and Functional Outcome After TKA

Status:
Enrolling by invitation

Trial end date:
2022-12-31

Target enrollment:
0

Participant gender:
All

Summary

Patients previously included in the DEX-2-TKA-trial (ethics committee ID SJ-695; ClinicalTrials.gov: NCT03506789) at Næstved Hospital will be invited for a follow up study consisting of questionnaires and a visit with a physical therapist. The study includes the following validated questionnaires: EQ-5D-5L, Oxford Knee Score and PainDetect, and information on height, weight, daily pain-medication and co-morbidities. With the physical therapist, the patient will perform the following functional tests: knee range of motion, timed-up-to-go, 30 second chair stand test, 40m fast paced walk test, stair climb test and a measure of the thigh force.

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Slagelse Hospital

Treatments:

Dexamethasone

Criteria

Inclusion Criteria:

- participation in the DEX-2-TKA-trial at Næstved Hospital in accordance with protocol

- Signed, informed consent for participation

Exclusion Criteria:

- Lack of signed, informed consent